Recent Posts
- Bora Pharmaceuticals Wins Dual Honors at the Taiwan MAPECT M&A Ceremony: “Deal of the Year” Award and “Best Cross-Border M&A” Award
- Bora Pharmaceuticals to Expand Rare Disease Portfolio with Acquisition of US-Based Pyros Pharmaceuticals
- Bora Appoints J.D. Mowery As First Division President Of Its CDMO Business
- Tanvex Appoints Biopharma Industry Veteran Stephen Lam as CEO
- Bora Pharmaceuticals Makes a Strategic Investment into Tanvex to Provide Global BioManufacturing Services.